Qube Research & Technologies (QRT)
CRMD icon

Qube Research & Technologies (QRT)’s CorMedix CRMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-637,497
Closed -$7.41M – 3746
2025
Q3 		$7.41M Buy
637,497
+422,277
+196% +$5.11M 0.01% 1500
2025
Q2 		$2.65M Buy
215,220
+91,720
+74% +$1.01M ﹤0.01% 2063
2025
Q1 		$761K Buy
+123,500
New +$1.28M ﹤0.01% 2377
2023
Q2 		– Sell
-12,938
Closed -$53.6K – 2486
2023
Q1 		$53.6K Sell
12,938
-22,707
-64% -$92.9K ﹤0.01% 2219
2022
Q4 		$150K Buy
35,645
+8,685
+32% +$30.7K ﹤0.01% 1896
2022
Q3 		$76K Sell
26,960
-4,340
-14% -$18.1K ﹤0.01% 2049
2022
Q2 		$126K Buy
+31,300
New +$116K ﹤0.01% 1856
2021
Q3 		– Sell
-28,771
Closed -$197K – 2294
2021
Q2 		$197K Buy
+28,771
New +$229K ﹤0.01% 1801

Other funds holding CRMD

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return